Derleme

Effects of Treatments Applied in Myasthenia Gravis on Gait: Review

Sayı: 22 30 Nisan 2024
PDF İndir
EN TR

Effects of Treatments Applied in Myasthenia Gravis on Gait: Review

Abstract

Myasthenia Gravis (MG) is an autoimmune disease in which neuromuscular transmission is blocked and neuromuscular junction physiology is affected. The main feature in MG is altered muscle weakness and fatigue of muscle groups that worsens with exercise and improves with rest. With the emergence of muscle weakness in the following periods, walking is affected in MG. This causes balance and walking problems. Most of the patients have complaints of falling and fear of falling. While applying MG treatment, myasthenic symptoms should be reduced and a stable clinical picture should be obtained in which the daily activities of the person are relieved. The aim of this study is to understand the effect of rehabilitation practices on gait in MG and to determine which exercises are effective. As a result, physiotherapy and rehabilitation approaches can provide solutions to patients' complaints, albeit symptomatically. Active resistance exercises, aerobic exercises, balance strategy training, endurance exercises, posture exercises, stretching exercises and active–passive range of motion exercises should be performed in an exercise program. In addition, rhythmic auditory stimulation and pre-surgical respiratory physiotherapy also have positive effects on walking.

Keywords

Kaynakça

  1. 1. Kılınç M, Savcun Demirci C, Ayvat E, Aksu Yıldırım S. Nöromusküler Hastalıklar. In: Karaduman AA, Tunca Yılmaz Ö, ed(s). Fizyoterapi ve Rehabilitasyon Cilt 3. 1st ed. Ankara: Hipokrat Kitabevi; 2017:49-61.
  2. 2. Patrick J, Lindstrom J. Autoimmune response to acetylcholine receptor. Science. 1973;180(4088):871-872.
  3. 3. Gilhus NE, Verschuuren JJ, Hovland SIB, Simmonds H, Groot F, Palace J. Myasthenia gravis: do not forget the patient perspective. Neuromuscular Disorders. 2021;31(12):1287-1295.
  4. 4. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value. Neurology. 1976;26(11):1054-1054.
  5. 5. Aydın Ş. Miyastenia gravis. Güncel Göğüs Hastalıkları Serisi. 2020;8(3):70-80.
  6. 6. Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurology. 2010;10:1-9.
  7. 7. Marx A, Willcox N, Leite MI, et al. Thymoma and paraneoplastic myasthenia gravis. Autoimmunity. 2010;43(5-6):413-427.
  8. 8. Marx A, Pfister F, Schalke B, Saruhan Direskeneli G, Melms A, Ströbel P. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmunity Reviews. 2013;12(9):875-884.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Fizyoterapi

Bölüm

Derleme

Erken Görünüm Tarihi

27 Nisan 2024

Yayımlanma Tarihi

30 Nisan 2024

Gönderilme Tarihi

3 Temmuz 2023

Kabul Tarihi

13 Mart 2024

Yayımlandığı Sayı

Yıl 2024 Sayı: 22

Kaynak Göster

JAMA
1.Aydın S, Kethüdaoğlu MO, Göçen HB, Albayrak HE, Köseoğlu A, Altunok MK, Özsezikli BA. Effects of Treatments Applied in Myasthenia Gravis on Gait: Review. IGUSABDER. 2024;:459–467.

Cited By

 Alıntı-Gayriticari-Türetilemez 4.0 Uluslararası (CC BY-NC-ND 4.0)